Abraxane Interactions
There are 513 drugs known to interact with Abraxane (paclitaxel protein-bound), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 60 are major, 435 are moderate, and 18 are minor.
- View all 513 medications that may interact with Abraxane
- View Abraxane alcohol/food interactions (1)
- View Abraxane disease interactions (4)
Most frequently checked interactions
View interaction reports for Abraxane (paclitaxel protein-bound) and the medicines listed below.
- amlodipine
- Ativan (lorazepam)
- atorvastatin
- Benadryl (diphenhydramine)
- capecitabine
- carboplatin
- dexamethasone
- doxycycline
- Eliquis (apixaban)
- Faslodex (fulvestrant)
- furosemide
- gabapentin
- gemcitabine
- Gemzar (gemcitabine)
- levothyroxine
- lorazepam
- metformin
- Neulasta (pegfilgrastim)
- omeprazole
- ondansetron
- oxycodone
- paclitaxel
- potassium chloride
- prochlorperazine
- Synthroid (levothyroxine)
- tramadol
- Vitamin D3 (cholecalciferol)
- Xeloda (capecitabine)
- Zofran (ondansetron)
- Zometa (zoledronic acid)
Abraxane alcohol/food interactions
There is 1 alcohol/food interaction with Abraxane (paclitaxel protein-bound).
Abraxane disease interactions
There are 4 disease interactions with Abraxane (paclitaxel protein-bound) which include:
Report options
QR code containing a link to this page
More about Abraxane (paclitaxel protein-bound)
- Abraxane consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: mitotic inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.